Benzinga | Nov 3, 2021 09:19AM EDT

Oppenheimer Maintains Outperform on Incyte, Lowers Price Target to $109

Oppenheimer analyst Jay Olson maintains Incyte (NASDAQ:INCY) with a Outperform and lowers the price target from $110 to $109.